The YOU-Fish Study: Fish and Omega 3 Supplementation in Young Adults
NCT06729229 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2024-12-11
Summary
Cardiovascular disease (CVD) is one of the major causes of mortality, however, it is estimated that approximately 75% of all cases are preventable. Previous evidence has shown higher blood concentrations of n-3 polyunsaturated fatty acids (PUFAs) are associated with a lower risk of cardiovascular disease owing to their ability to lower inflammation. The omega-3 index (O3I) is a commonly used marker of n-3 PUFA status, which refers to the percentage of n-3 long chain PUFAs (with respect to total fatty acids) in red blood cell membranes, with an O3I of \>8% associated with the lowest risk of CVD. Concerningly it's estimated that most of the population have an O3I ranging from 4-5%. Fish is a rich source of polyunsaturated fatty acids (PUFA) and has been shown to be one of the main predictors of a higher O3I. Current guidelines recommend the consumption of 2 portions of fish per week; however, current UK and Irish intakes are well below the current recommendations, particularly amongst young people. Additionally, professional bodies have noted that a daily omega-3 supplement, providing approximately 500mg EPA + DHA per day, is beneficial in increasing omeag-3 intakes amongst those who may exclude dietary sources such as fish. The regular consumption of fish or omega 3 supplement use could help to increase the O3I, however, it remains unknown as to whether the guidance surrounding these methods are effective in reaching the recommended target of 8%. Early interventions such as increasing the O3I (throughfish and/or supplements) into a lower risk category may be an effective intervention in the prevention of CVD. This human intervention study will investigate the effects of omega 3 supplements and fish on the O3I and vascular health of young adults. It is hypothesised that increasing fish consumption or taking omega 3 supplements will increase the O3I and improve the vascular health of young adults.
Conditions
- Cardiovascular Prevention
Interventions
- DIETARY_SUPPLEMENT
-
Placebo
Experimental - 2 portions of fish (280g) per week and placebo supplement (corn oil)
- DIETARY_SUPPLEMENT
-
Dietary Supplement/Vitamins
Experimental - Control lunch (no fish) and omega 3 supplement
- DIETARY_SUPPLEMENT
-
Placebo
Placebo comparator - Control lunch (no fish) and placebo supplement
- DIETARY_SUPPLEMENT
-
Dietary Supplement/Vitamins
Experimental - 2 portions of fish (280g) per week and omega 3 supplement
Sponsors & Collaborators
-
University of Ulster
lead OTHER
Principal Investigators
-
Emeir McSorley, PhD · Ulster University, Cromore Road, Coleraine, Co. Londonderry, BT521SA.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-12-01
- Primary Completion
- 2025-06-30
- Completion
- 2025-07-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Erythrocyte Omega-3 Fatty Acid Content in Elite Athletes
NCT02610270 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Efficacy Study Regarding the Beneficial Effects of Omega-3 Fatty Acids on Cardiometabolic Health
NCT02042274 ·Status: COMPLETED ·Phase: NA
-
Personalized Nutrition in Young Adults: The Ability of Genetic Information to Motivate Changes in Omega-3 Consumption
NCT02829138 ·Status: COMPLETED ·Phase: NA
-
Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers
NCT00682318 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Intervention With Vitamin D and Omega-3 Supplements and Incident Heart Failure
NCT02271230 ·Status: COMPLETED ·Phase: PHASE3
-
Potential Effects of Omega 3 Supplementation on Cardiomyocytes Membranes for Patients With Coronary Atherosclerosis?
NCT01699230 ·Status: UNKNOWN ·Phase: PHASE3
-
Effects of Omega-3 Docosapentaenoic Acid on Lipids and Other Risk Factors for Cardiovascular Disease
NCT04088240 ·Status: TERMINATED ·Phase: NA
-
Meta-analysis of Fish Oil Supplementation and Cardiovascular Outcomes in Diabetes
NCT04327713 ·Status: UNKNOWN
-
Omega-3-Index Response to Eating Poultry Foods Naturally Enriched With Omega-3 Polyunsaturated Fatty Acids
NCT06259825 ·Status: RECRUITING ·Phase: NA
-
Effect of Omega 3 Fatty Acids on Vascular Function
NCT01888211 ·Status: COMPLETED ·Phase: NA
-
The Impact of Fish-oil Fatty Acids on Postprandial Vascular Reactivity
NCT01692431 ·Status: COMPLETED ·Phase: NA
-
Effect of Fish Consumption on Cardiovascular Risk Factors
NCT03111784 ·Status: COMPLETED ·Phase: NA
-
Investigating the Effect of 4-week Omega-3 Polyunsaturated Fatty Acid Supplementation on Inflammation
NCT03210805 ·Status: UNKNOWN ·Phase: NA
-
Impacts of Omega-3-PUFA Enriched Chicken-meat and Eggs in Healthy Humans
NCT04127409 ·Status: COMPLETED ·Phase: NA
-
Effects of 12 Weeks of Omega 3 Supplementation on Resting Metabolic Rate
NCT02092649 ·Status: COMPLETED ·Phase: NA
-
Effect of 12 wk of Omega-3 FA Supplementation on Metabolic and Physical Health Parameters in Older Adults
NCT01734538 ·Status: UNKNOWN ·Phase: NA
-
N-3 Polyunsaturated Fatty Acids Enriched Chicken Meet and Cardiovascular Function
NCT05725486 ·Status: UNKNOWN ·Phase: NA
-
Effect of Plant Omega-3 and Omega-6 Fatty Acids on Exercise Performance
NCT02654392 ·Status: UNKNOWN ·Phase: NA
-
Omega-3D: Omega-3 for Diet-Driven Health Disparities
NCT07078344 ·Status: RECRUITING ·Phase: PHASE2
-
Diet and Omega-3 Intervention Trial on Atherosclerosis
NCT00764010 ·Status: COMPLETED ·Phase: PHASE3
-
Omega-3 Fatty Acids Enriched Food and Microvascular Reactivity
NCT02720250 ·Status: UNKNOWN ·Phase: NA
-
Assessing the Effects of Omega-3 Supplementation on Serum HSP27, HSP70, YKL40, BMP-4 Levels in Male Patient With CAD
NCT02117960 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Fish Oil Dose on Tissue Content and Function
NCT04772040 ·Status: COMPLETED ·Phase: NA
-
Krill Oil as Supplementation to Healthy Young Adults.
NCT02053415 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Fatty Acids, the Omega-3 Index, and Atherosclerosis
NCT00886704 ·Status: COMPLETED ·Phase: NA